US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

LUCD

Lucid Diagnostics (LUCD)

Lucid Diagnostics Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:LUCD

1 2 3 4 5 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
14/05/2024	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUCD	Lucid Diagnostics Inc
13/05/2024	19:43	PR Newswire (US)	PAVmed Provides Business Update and First Quarter 2024 Financial Results	NASDAQ:LUCD	Lucid Diagnostics Inc
13/05/2024	07:21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LUCD	Lucid Diagnostics Inc
13/05/2024	07:00	PR Newswire (US)	Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results	NASDAQ:LUCD	Lucid Diagnostics Inc
09/05/2024	20:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LUCD	Lucid Diagnostics Inc
09/05/2024	20:57	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:LUCD	Lucid Diagnostics Inc
09/05/2024	06:49	PR Newswire (US)	Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall	NASDAQ:LUCD	Lucid Diagnostics Inc
07/05/2024	06:39	PR Newswire (US)	Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors	NASDAQ:LUCD	Lucid Diagnostics Inc
02/05/2024	07:35	PR Newswire (US)	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024	NASDAQ:LUCD	Lucid Diagnostics Inc
02/05/2024	06:49	PR Newswire (US)	Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing	NASDAQ:LUCD	Lucid Diagnostics Inc
29/04/2024	07:47	PR Newswire (US)	Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month	NASDAQ:LUCD	Lucid Diagnostics Inc
08/04/2024	07:30	PR Newswire (US)	Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:LUCD	Lucid Diagnostics Inc
26/03/2024	18:32	PR Newswire (US)	PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:LUCD	Lucid Diagnostics Inc
25/03/2024	16:30	PR Newswire (US)	Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:LUCD	Lucid Diagnostics Inc
21/03/2024	08:30	PR Newswire (US)	Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population	NASDAQ:LUCD	Lucid Diagnostics Inc
20/03/2024	07:30	PR Newswire (US)	Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference	NASDAQ:LUCD	Lucid Diagnostics Inc
12/03/2024	07:30	PR Newswire (US)	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024	NASDAQ:LUCD	Lucid Diagnostics Inc
16/02/2024	16:00	PR Newswire (US)	Lucid Diagnostics Provides Update Regarding World Trade Center Health Program	NASDAQ:LUCD	Lucid Diagnostics Inc
15/02/2024	06:45	PR Newswire (US)	Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony	NASDAQ:LUCD	Lucid Diagnostics Inc
08/02/2024	06:45	PR Newswire (US)	Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors	NASDAQ:LUCD	Lucid Diagnostics Inc
06/02/2024	16:24	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:LUCD	Lucid Diagnostics Inc
12/12/2023	07:30	PR Newswire (US)	Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies	NASDAQ:LUCD	Lucid Diagnostics Inc
11/12/2023	08:00	PR Newswire (US)	PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders	NASDAQ:LUCD	Lucid Diagnostics Inc
04/12/2023	15:20	PR Newswire (US)	PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split	NASDAQ:LUCD	Lucid Diagnostics Inc
16/11/2023	08:00	PR Newswire (US)	Lucid Diagnostics Strengthens and Expands Market Access and Direct Contracting Efforts	NASDAQ:LUCD	Lucid Diagnostics Inc
14/11/2023	16:43	PR Newswire (US)	PAVmed Provides Business Update and Third Quarter Financial Results	NASDAQ:LUCD	Lucid Diagnostics Inc
13/11/2023	16:40	PR Newswire (US)	Lucid Diagnostics Provides Business Update and Third Quarter Financial Results	NASDAQ:LUCD	Lucid Diagnostics Inc
09/11/2023	08:00	PR Newswire (US)	Lucid Diagnostics Launches Next-Generation EsoGuard® Esophageal DNA Test and Announces Upcoming Investor Day	NASDAQ:LUCD	Lucid Diagnostics Inc
02/11/2023	08:18	PR Newswire (US)	Lucid Diagnostics to Present at Canaccord Genuity Medtech, Diagnostics, and Digital Health & Services Forum	NASDAQ:LUCD	Lucid Diagnostics Inc
01/11/2023	15:21	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:LUCD	Lucid Diagnostics Inc

Showing the most relevant articles for your search:NASDAQ:LUCD

1 2 3 4 5 Próxima >

VALEF11 Ex:97,99

Lg Enco Usd Dis

Dimensional ETF

HIWIN Technologies (PK)

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones